Correction to “Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open-label extension study”

IF 6.6 1区 医学 Q1 CLINICAL NEUROLOGY Epilepsia Pub Date : 2024-05-30 DOI:10.1111/epi.17999
{"title":"Correction to “Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open-label extension study”","authors":"","doi":"10.1111/epi.17999","DOIUrl":null,"url":null,"abstract":"<p>Knupp KG, Scheffer IE, Ceulemans B, et al. Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open-label extension study. <i>Epilepsia</i>. 2023;64(1):139–151. doi:10.1111/epi.17431</p><p>In Paragraph 2 on page 145 of Section 3.3 (“Effectiveness”) of the “Results” section, the following sentences contained data describing typical, non-ESC-confirmed drop seizures:</p><p>“In the overall treatment period, median percentage increase in days free of drop seizures was 41.6% compared to pretreatment baseline in the core RCT, with a median absolute change of 1.93 days per 28 days (range = −23.0 to 27.5 days; <i>p</i> &lt; .0001). The longest interval between drop seizures increased from a median of 2.0 days (range = 1–17 days) to a median of 6.0 days (range = 1–365 days).”</p><p>The data ‘41.6%’, ‘1.93 days’, ‘27.5 days’, and ‘6.0 days’ needs to be updated for consistency with the data reported in the rest of the manuscript. The data in this paragraph should be updated to ESC-confirmed drop seizures, as shown below:</p><p>“In the overall treatment period, median percentage increase in days free of drop seizures was 44.6% compared to pretreatment baseline in the core RCT, with a median absolute change of 2.03 days per 28 days (range = −23.0 to 27.8 days; <i>p</i> &lt; .0001). The longest interval between drop seizures increased from a median of 2.0 days (range = 1–17 days) to a median of 7.0 days (range = 1–365 days).”</p><p>The data ‘41.6%’ becomes ‘44.6%’, ‘1.93 days’ becomes ‘2.03 days’, ‘27.5 days’ becomes ‘27.8 days’, and ‘6.0 days’ becomes ‘7.0 days’.</p><p>In Table 2 on page 144 of Section 3.2 of the “Results”, the text “.3 to .5” should be “.3 to &lt;.5”. In the next row, the text “&gt;.5 to .7” should be “≥.5 to .7”.</p><p>In the first paragraph of Section 3.2 of the “Results” on page 144, line 5, the text “.3 - .5 mg/kg/day” should be “.3 - &lt;.5 mg/kg/day”.</p><p>We confirm that these corrections do not change the interpretation of our results. We apologize for these errors.</p>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":null,"pages":null},"PeriodicalIF":6.6000,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/epi.17999","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epilepsia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/epi.17999","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Knupp KG, Scheffer IE, Ceulemans B, et al. Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open-label extension study. Epilepsia. 2023;64(1):139–151. doi:10.1111/epi.17431

In Paragraph 2 on page 145 of Section 3.3 (“Effectiveness”) of the “Results” section, the following sentences contained data describing typical, non-ESC-confirmed drop seizures:

“In the overall treatment period, median percentage increase in days free of drop seizures was 41.6% compared to pretreatment baseline in the core RCT, with a median absolute change of 1.93 days per 28 days (range = −23.0 to 27.5 days; p < .0001). The longest interval between drop seizures increased from a median of 2.0 days (range = 1–17 days) to a median of 6.0 days (range = 1–365 days).”

The data ‘41.6%’, ‘1.93 days’, ‘27.5 days’, and ‘6.0 days’ needs to be updated for consistency with the data reported in the rest of the manuscript. The data in this paragraph should be updated to ESC-confirmed drop seizures, as shown below:

“In the overall treatment period, median percentage increase in days free of drop seizures was 44.6% compared to pretreatment baseline in the core RCT, with a median absolute change of 2.03 days per 28 days (range = −23.0 to 27.8 days; p < .0001). The longest interval between drop seizures increased from a median of 2.0 days (range = 1–17 days) to a median of 7.0 days (range = 1–365 days).”

The data ‘41.6%’ becomes ‘44.6%’, ‘1.93 days’ becomes ‘2.03 days’, ‘27.5 days’ becomes ‘27.8 days’, and ‘6.0 days’ becomes ‘7.0 days’.

In Table 2 on page 144 of Section 3.2 of the “Results”, the text “.3 to .5” should be “.3 to <.5”. In the next row, the text “>.5 to .7” should be “≥.5 to .7”.

In the first paragraph of Section 3.2 of the “Results” on page 144, line 5, the text “.3 - .5 mg/kg/day” should be “.3 - <.5 mg/kg/day”.

We confirm that these corrections do not change the interpretation of our results. We apologize for these errors.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对 "芬氟拉明可减少伦诺克斯-加斯豪特综合征患者的癫痫发作频率,具有临床意义:开放标签扩展研究的中期分析 "的更正。
Knupp KG, Scheffer IE, Ceulemans B, et al. 芬氟拉明可显著降低伦诺克斯-加斯陶特综合征患者的癫痫发作频率:一项开放标签扩展研究的中期分析。Epilepsia.2023;64(1):139–151. doi:10.1111/epi.17431在第 145 页 "结果 "部分第 3.3 节("疗效")的第 2 段中,以下句子包含描述典型、非 ESC 确诊的跌扑发作的数据:"在整个治疗期间,与核心 RCT 的治疗前基线相比,无跌扑发作天数的中位百分比增加了 41.6%,每 28 天的中位绝对变化为 1.93 天(范围 = -23.0 至 27.5 天;p < .0001)。癫痫发作的最长间隔时间从中位数2.0天(范围=1-17天)增加到中位数6.0天(范围=1-365天)。"'41.6%'、'1.93天'、'27.5天'和'6.0天'这些数据需要更新,以便与手稿其余部分报告的数据保持一致。本段中的数据应更新为ESC确诊的滴注发作,如下所示:"在整个治疗期间,与核心RCT治疗前基线相比,无滴注发作天数的中位百分比增加了44.6%,每28天的中位绝对变化为2.03天(范围=-23.0至27.8天;p< .0001)。癫痫发作的最长间隔时间从中位数 2.0 天(范围 = 1-17 天)增加到中位数 7.0 天(范围 = 1-365 天)。"数据'41.6%'变为'44.6%','1.93 天'变为'2.结果 "第 3.2 部分第 144 页的表 2 中,".3 至 .5 "应为".3 至 <.5"。在第 144 页 "结果 "第 3.2 节第一段第 5 行,".3-.5 毫克/千克/天 "应为".3-<.5 毫克/千克/天"。我们确认这些更正不会改变我们对结果的解释。我们对这些错误表示歉意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Epilepsia
Epilepsia 医学-临床神经学
CiteScore
10.90
自引率
10.70%
发文量
319
审稿时长
2-4 weeks
期刊介绍: Epilepsia is the leading, authoritative source for innovative clinical and basic science research for all aspects of epilepsy and seizures. In addition, Epilepsia publishes critical reviews, opinion pieces, and guidelines that foster understanding and aim to improve the diagnosis and treatment of people with seizures and epilepsy.
期刊最新文献
Histopathological substrate of increased T2 signal in the anterior temporal lobe white matter in temporal lobe epilepsy associated with hippocampal sclerosis. Imaging blood-brain barrier dysfunction in drug-resistant epilepsy: A multi-center feasibility study. Long-term neuroplasticity in language networks after anterior temporal lobe resection. Eating habits and behaviors in children with Dravet syndrome: A case-control study. Machine learning for forecasting initial seizure onset in neonatal hypoxic-ischemic encephalopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1